DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival-MedSci.cn

DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival

Klempner, SJ; Bendell, JC; Villaflor, VM; Tenner, LL; Stein, S; Naik, GS; Sirard, CA; Kagey, M; Chaney, MF; Strickler, JH

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (4):

科室
- - 订阅+
  - 更多科室
工具
服务